$HONA

Honeywell Aerospace upgraded to Overweight by Morgan Stanley

Honeywell Aerospace (HONA) shares rose 5.5% after Morgan Stanley upgraded it to Overweight with a $205 price target. The firm cited attractive valuations at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, despite operational challenges and legal investigations. The company reported Q2 sales of $4.52B and an $18.2B backlog but cut full-year guidance due to supply chain issues.

Original reporting
Published Aug 19, 2026, 3:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 4:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Honeywell Aerospace upgraded to Overweight by Morgan Stanley — source image
Decision brief

The 30-second read

$HONANeutralHigh
01

Why it matters

The upgrade signals analyst confidence in valuation, yet the guidance downgrade and multiple investigations introduce significant downside risk.

02

Market read

The combination of an analyst upgrade, fresh earnings guidance cuts, and legal scrutiny creates a complex trade narrative for HONA.

03

What to watch

Potential supply‑chain bottlenecks and ongoing securities fraud probes may depress earnings beyond current guidance.

Relevance 8/10Novelty 8/10Timing: pre‑market Wednesday

Background

Honeywell Aerospace recently spun off from Honeywell International and reported its first standalone earnings, revealing operational challenges.

Company-level read

Ticker impact

$HONANeutralHigh confidence
Context

Morgan Stanley upgraded Honeywell Aerospace to Overweight with a $205 price target and disclosed fresh Q2 earnings and guidance cuts.

Expected impact

Potential short-term pullback to $160-165, with upside to $205 if valuation re-rates.

Evidence & confidence

The upgrade provides a concrete entry point, but the guidance cut and legal investigations increase risk, leading to mixed price expectations.

Market effects

Affects aerospace sector valuations as peers may be re‑rated relative to Honeywell Aerospace's discount.

U.S. aerospace stocks may see volatility; investors may rotate into other large‑cap aerospace names.

Limited to U.S. markets but could influence global aerospace supply‑chain sentiment.

Counterpoint

The legal investigations and guidance cuts could outweigh the upgrade, suggesting a short position.

Key entities

  • Morgan Stanley

    Upgraded Honeywell Aerospace to Overweight with a $205 price target.

  • Robbins Geller Rudman & Dowd LLP

    Launched a securities fraud investigation into Honeywell Aerospace.

Related articles

$HONAHighAI 9/10

A $1.5 Trillion Defense Budget Is on the Table. Here's the 1 Defense Stock I'd Buy First.

Honeywell Aerospace (HONA) is highlighted as a potential investment opportunity due to increased global defense spending and strong demand for aircraft parts. The company reported Q2 revenue of $4.5B, up 5% YoY, but EPS fell 71% to $0.78. It adjusted full-year guidance, reducing organic growth and EBIT expectations. Analysts see upside, with an average price target of $213, 35% above current levels. The company's backlog grew 9% YoY to $18.2B, driven by defense modernization programs.

$HONMed

Honeywell Is Now Three Companies. Here's Which Piece I'd Actually Own.

Honeywell has split into three companies: Honeywell Technologies (HON), Solstice Advanced Materials (SOLS), and Honeywell Aerospace (HONA). Honeywell Technologies, led by CEO Vimal Kapur, reported strong automation sector growth with 16% order increase and 10% earnings growth. Solstice Advanced Materials showed 11% sales growth and 23% EPS increase, while Honeywell Aerospace lowered guidance.

$HONAHigh

Honeywell Aerospace Stock Upgraded to Overweight Following Sell-Off - Honeywell Aerospace (NASDAQ:HONA)

Morgan Stanley upgraded Honeywell Aerospace (HONA) to Overweight with a $205 price target, citing a 25% sell-off post-spin-off and discounted valuation. HONA trades at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, 35-38% below peers. Q2 sales were $4.52B, up 5% organically, but supply chain issues led to trimmed guidance. CEO Jim Currier acknowledged execution delays but noted localized issues and efforts to dual-source suppliers and expand capacity.